Exchange: OTC·Updated 09:30 AM EDT

IUGNF Imugene Limited

$0.0966
$0.0212
(28.12%)
Today
Mkt Cap$47.31M
Vol1,008.00

About IUGNF

Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialization of immunotherapies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Sydney, Australia.
50

Neutral Sentiment

How do you feel about IUGNF?

Advertisement|Remove ads.